These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15803191)

  • 1. Melanocytic lesions associated with dermatofibromas: a spectrum of lesions ranging from junctional nevus to malignant melanoma in situ.
    King R; Googe PB; Page RN; Mihm MC
    Mod Pathol; 2005 Aug; 18(8):1043-7. PubMed ID: 15803191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmoplastic (sclerotic) nevus: an underrecognized entity that resembles dermatofibroma and desmoplastic melanoma.
    Harris GR; Shea CR; Horenstein MG; Reed JA; Burchette JL; Prieto VG
    Am J Surg Pathol; 1999 Jul; 23(7):786-94. PubMed ID: 10403301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The usefulness of c-Kit in the immunohistochemical assessment of melanocytic lesions.
    Pilloni L; Bianco P; Difelice E; Cabras S; Castellanos ME; Atzori L; Ferreli C; Mulas P; Nemolato S; Faa G
    Eur J Histochem; 2011 Jun; 55(2):e20. PubMed ID: 22193299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma associated with a dermatofibroma.
    Kovach BT; Boyd AS
    J Cutan Pathol; 2007 May; 34(5):420-2. PubMed ID: 17448199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Melan-A in Spitz, pigmented spindle cell nevi, and congenital nevi: comparative immunohistochemical study.
    Evans MJ; Sanders DS; Grant JH; Blessing K
    Pediatr Dev Pathol; 2000; 3(1):36-9. PubMed ID: 10644168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A unique biphasic variant of cutaneous fibrous histiocytoma with a storiform pattern and intralesional pigmented melanocytes: "storiform melano-fibrous histiocytoma".
    Nair V; Weinreb I; MacNeil N; Szollosi Z; Chetty R; Ghazarian D
    Eur J Dermatol; 2008; 18(3):332-6. PubMed ID: 18474466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentiginous melanocytic hyperplasia overlying dermatofibroma.
    Toda S; Heasley DD; Carlson JA; Mihm MC
    J Dermatol; 1996 Nov; 23(11):840-4. PubMed ID: 8990711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the proliferation and apoptosis-associated CAS protein in benign and malignant cutaneous melanocytic lesions.
    Böni R; Wellmann A; Man YG; Hofbauer G; Brinkmann U
    Am J Dermatopathol; 1999 Apr; 21(2):125-8. PubMed ID: 10218671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative activity of primary cutaneous melanocytic tumours.
    Kuwata T; Kitagawa M; Kasuga T
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):359-64. PubMed ID: 7906909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100A6 expression in fibrohistiocytic lesions.
    Fullen DR; Reed JA; Finnerty B; McNutt NS
    J Cutan Pathol; 2001 May; 28(5):229-34. PubMed ID: 11401666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentiginous melanoma: a histologic pattern of melanoma to be distinguished from lentiginous nevus.
    King R; Page RN; Googe PB; Mihm MC
    Mod Pathol; 2005 Oct; 18(10):1397-401. PubMed ID: 15976811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staining of melanocytic neoplasms by melanoma antigen recognized by T cells.
    Mehregan DR; Hamzavi I
    Am J Dermatopathol; 2000 Jun; 22(3):247-50. PubMed ID: 10871068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
    Busam KJ; Chen YT; Old LJ; Stockert E; Iversen K; Coplan KA; Rosai J; Barnhill RL; Jungbluth AA
    Am J Surg Pathol; 1998 Aug; 22(8):976-82. PubMed ID: 9706977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
    Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
    J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells.
    Kopera D; Hohenleutner U; Stolz W; Landthaler M
    Dermatology; 1997; 194(4):344-50. PubMed ID: 9252755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reactivity of five different antibodies with benign and malignant melanocytic lesions].
    Plótár V; Szentirmay Z; Orosz Z
    Magy Onkol; 2008 Dec; 52(4):363-73. PubMed ID: 19068464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical studies of conjunctival nevi and melanomas.
    Jakobiec FA; Bhat P; Colby KA
    Arch Ophthalmol; 2010 Feb; 128(2):174-83. PubMed ID: 20142539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiated squamous intraepithelial lesion (dSIL)-like changes in the epidermis overlying anogenital melanocytic nevi: A diagnostic pitfall.
    Michalova K; Kazakov DV; Michal M; Hadravsky L; Kacerovska D; Rychly B; Miesbauerova M; Michal M
    Ann Diagn Pathol; 2017 Feb; 26():43-46. PubMed ID: 28038710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions.
    de Vries TJ; Fourkour A; Wobbes T; Verkroost G; Ruiter DJ; van Muijen GN
    Cancer Res; 1997 Aug; 57(15):3223-9. PubMed ID: 9242453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanotic pigmentation in excision scars of melanocytic and non-melanocytic skin tumors.
    Botella-Estrada R; Sanmartín O; Sevila A; Escudero A; Guillén C
    J Cutan Pathol; 1999 Mar; 26(3):137-44. PubMed ID: 10235379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.